ecp.upneeq.comUpneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% Daily Eye Drop

Upneeq Home About Acquired Blepharoptosis (Low-Lying Lids) Common Eyelid Disorder Check Low-Lying Lids/Start a Dialogue What Upneeq Offers Your Patients First-In-Class Treatment Rapid Visual Lift/Visual Field Improvement Safety and Tolerability Peer Reviewed Publications Getting Your Patient Started With Upneeq Applying Upneeq Modernizing Prescription Access How RVL Pharmacy Works Prescribing Upneeq ECP FAQs Pharmacy Resources Resource Library and Find-A-Specialist Resource Library Join Find-A-Specialist Register Login Digital Assets Request Samples Contact Us For Patients Prescribing Information Important Safety Information F-A-S Login header Facebook page opens in new window Instagram page opens in new window YouTube page opens in new window Home About Acquired Blepharoptosis (Low-Lying Lids) Common Eyelid Disorder Check Low-Lying Lids/Start a Dialogue What Upneeq Offers Your Patients First-In-Class Treatment Rapid Visual Lift/Visual Field Improvement Safety and Tolerability Peer Reviewed Publications Getting Your Patient Started With Upneeq Applying Upneeq Modernizing Prescription Access How RVL Pharmacy Works Prescribing Upneeq ECP FAQs Pharmacy Resources Resource Library and Find-A-Specialist Resource Library Join Find-A-Specialist Register Login Digital Assets AS SEEN IN Unless otherwise indicated, all images depict actor portrayals. A Nonsurgical Solution for Your Acquired Ptosis Patients Low-lying lids may be caused by acquired blepharoptosis. If you see signs of low-lying lids in your patients, talk to them about getting UPLIFTED with Upneeq! 1 About acquired blepharoptosis This common condition (also called low-lying lids) can impact adults of all ages. 2,3 START THE CONVERSATION WITH YOUR PATIENTS. Get Your Patient Started What Upneeq offers your patients The first FDA-approved once-daily prescription eyedrop proven to rapidly lift the upper eyelid. 1,4 SEE WHAT U CAN DO Get Your Patient Started Getting Your Patient Started With Upneeq We modernize prescription access for your patients. LEARN HOW RVL PHARMACY SIMPLIFIES THE JOURNEY Get Your Patient Started Upneeq Resource Library Get helpful information and social media resources about Upneeq and RVL Pharmacy. CLICK HERE FOR ADDITIONAL RESOURCES Get Your Patient Started Join Upneeq FIND-A-SPECIALIST Sign up today to help patients find your practice. REGISTER LOGIN EXPAND COLLAPSE INDICATION UPNEEQ ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is indicated for the treatment of acquired blepharoptosis in adults. IMPORTANT SAFETY INFORMATION WARNINGS AND PRECAUTIONS Ptosis may be associated with neurologic or orbital diseases such as stroke and/or cerebral aneurysm, Horner syndrome, myasthenia gravis, external ophthalmoplegia, orbital infection and orbital masses. Consideration should be given to these conditions in the presence of ptosis with decreased levator muscle function and/or other neurologic signs. Alpha-adrenergic agonists as a class may impact blood pressure. Advise UPNEEQ patients with cardiovascular disease, orthostatic hypotension, and/or uncontrolled hypertension or hypotension to seek medical care if their condition worsens. Use UPNEEQ with caution in patients with cerebral or coronary insufficiency or Sjögren’s syndrome. Advise patients to seek medical care if signs and symptoms of potentiation of vascular insufficiency develop. UPNEEQ may increase the risk of angle closure glaucoma in patients with untreated narrow-angle glaucoma. Advise patients to seek immediate medical care if signs and symptoms of acute narrow-angle glaucoma develop. Patients should not touch the tip of the single patient-use container to their eye or to any surface, in order to avoid eye injury or contamination of the solution. ADVERSE REACTIONS Adverse reactions that occurred in 1-5% of subjects treated with UPNEEQ were punctate keratitis, conjunctival hyperemia, dry eye, blurred vision, instillation site pain, eye irritation and headache. DRUG INTERACTIONS Alpha-adrenergic agonists, as a class, may impact blood pressure. Caution in using drugs such as beta blockers, anti-hypertensives, and/or cardiac glycosides is advised. Caution should also be exercised in patients receiving alpha adrenergic receptor antagonists such as in the treatment of cardiovascular disease, or benign prostatic hypertrophy. Caution is advised in patients taking monoamine oxidase inhibitors which can affect the metabolism and uptake of circulating amines. To report SUSPECTED ADVERSE REACTIONS or product complaints, contact RVL Pharmaceuticals at 1-877-482-3788 . You may also report SUSPECTED ADVERSE REACTIONS to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . References: 1. Upneeq ® (oxymetazoline hydrochloride ophthalmic solution) 0.1%. [Prescribing Information]. RVL Pharmaceuticals, Inc. 2020. 2. Finsterer J. Ptosis: causes, presentation, and management. Aesthetic Plast Surg . 2003;27(3):193-204. 3. Richards HS, Jenkinson E, Rumsey N,et al. The psychological well- being and appearance concerns of patients presenting with ptosis. Eye . 2014; 28(3):296-302. 4. Data on file, RVL Pharmaceuticals, IncPrivacy Policy | Terms of Use | Contact Us ©2021 RVL Pharmaceuticals, Inc. All rights reserved. PM-US-UPN-0217-3 03/21 Upneeq ® is a registered trademark of RVL Pharmaceuticals, Inc. Distributed by: RVL Pharmaceuticals, Inc. Bridgewater, NJ 08807. X How can we help U? We would like to hear from you. If you should have a question about Upneeq ® , please submit your question here. Someone from the Upneeq team will respond to you. Click here for samples* Required Information Please enter your first name Please enter your last name Please enter your practice name Please enter your e-mail address Please enter your ZIP Please enter your phone number Question This form is not intended for the reporting of adverse events or product complaints associated with the use of prescription drugs. For medical information or to report adverse events/product complaints, please email us at MedicalInfo@rvlpharma.com or call 877-482-3788 . * Specialty Dermatology Facial Plastic Medical Aesthetics Ophthalmologist Optometrist Plastic Surgeon Please select specialty *I have reviewed and agree to RVL’s Privacy Statement and Terms of Use . Would you like to receive updates about Upneeq? I would like to receive information and other marketing communications about Upneeq and other products from RVL Pharmaceuticals, Inc. I understand that I can opt out of receiving emails at any time by clicking the unsubscribe link in any email. You must agree to our terms and conditions. The captcha field is requiredSUBMIT X Terms and Conditions Please read the terms and conditions of use carefully before accessing or using any materials, information or downloadable digital files ("Downloadable Content") on this site. By accessing, downloading, or using RVL Pharmaceuticals, Inc. ("RVL") Downloadable Content you agree to be bound by the terms and conditions set forth below. This site and all Downloadable Content are the property of RVL, and as such, are protected by U.S. Copyright and Intellectual Property laws. RVL reserves the right to rescind, revoke or amend the use of its Downloadable Content and/or the terms and conditions at any time. Where applicable, see the Instructions for Use contained within the zip file for instructions on use of Downloadable Content. If you are a healthcare professional or provider, you may print, share, and/or digitally display Downloadable Content from this site on social media channels, practice websites, and via e-mail with patients. No other permission or right is granted to you, to use, alter, modify or create derivative works of Downloadable Content without express written permission from RVL, or, unless expressly stated (e.g., addition of practice name, phone number, etc.). All social media Downloadable Content must be used in its entirety. Do not alter posts or captions. Downloadable Content cannot be used in any...